A detailed history of Royal Bank Of Canada transactions in 89bio, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 124,480 shares of ETNB stock, worth $993,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares
124,480
Previous 140,883 11.64%
Holding current value
$993,350
Previous $1.13 Million 18.35%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.36 - $9.66 $120,726 - $158,452
-16,403 Reduced 11.64%
124,480 $921,000
Q2 2024

Aug 14, 2024

BUY
$7.31 - $10.9 $72,273 - $107,768
9,887 Added 7.55%
140,883 $1.13 Million
Q1 2024

Nov 05, 2024

SELL
$8.13 - $13.77 $80,381 - $136,143
-9,887 Reduced 7.02%
130,996 $1.52 Million
Q1 2024

May 15, 2024

SELL
$8.13 - $13.77 $958,811 - $1.62 Million
-117,935 Reduced 47.38%
130,996 $1.52 Million
Q4 2023

Feb 14, 2024

BUY
$6.66 - $16.03 $156,057 - $375,614
23,432 Added 10.39%
248,931 $2.78 Million
Q3 2023

Nov 14, 2023

BUY
$15.06 - $19.41 $351,515 - $453,048
23,341 Added 11.55%
225,499 $3.48 Million
Q2 2023

Aug 14, 2023

BUY
$14.15 - $22.03 $32,856 - $51,153
2,322 Added 1.16%
202,158 $3.83 Million
Q1 2023

May 15, 2023

BUY
$10.48 - $16.94 $86,900 - $140,466
8,292 Added 4.33%
199,836 $3.04 Million
Q4 2022

Feb 14, 2023

BUY
$5.52 - $12.73 $333,176 - $768,357
60,358 Added 46.01%
191,544 $2.44 Million
Q3 2022

Nov 14, 2022

BUY
$3.02 - $7.0 $382,561 - $886,732
126,676 Added 2808.78%
131,186 $760,000
Q2 2022

Aug 15, 2022

SELL
$2.09 - $4.02 $63,966 - $123,036
-30,606 Reduced 87.16%
4,510 $15,000
Q1 2022

May 16, 2022

SELL
$3.45 - $14.99 $376 - $1,633
-109 Reduced 0.31%
35,116 $132,000
Q4 2021

Feb 14, 2022

SELL
$11.15 - $19.66 $701,134 - $1.24 Million
-62,882 Reduced 64.1%
35,225 $460,000
Q3 2021

Nov 15, 2021

BUY
$14.91 - $21.31 $573,155 - $819,177
38,441 Added 64.43%
98,107 $1.92 Million
Q2 2021

Aug 16, 2021

BUY
$17.42 - $28.0 $1.04 Million - $1.67 Million
59,666 New
59,666 $1.12 Million

Others Institutions Holding ETNB

About 89bio, Inc.


  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $371M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.